Caprotec Raises $5.1M to Apply Capture Compound Mass Spec Technology to Drug Development

The technology, which enables the isolation of functionally selected proteins from complex biological samples, has demonstrated potential usefulness in studying drug-protein interactions and could increase the efficiency of the drug development process.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.